DARE

$0.65-0.76%visit website

Dare Bioscience, Inc.

Market Cap

$10M

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.10

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

7.3

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	2	1,024	152	188	1,366
Cost of revenue			242	320
Research & development	1,175	622	660	242	2,700
Selling, general & administrative			2,249	2,594
Total operating expenses	3,674	2,199	2,909	2,836	11,618
Operating income	(3,672)	(1,471)	(2,999)	(2,968)	(11,110)
Net income	(3,563)	(1,442)	(3,000)	(2,983)	(10,987)
EPS (basic) ($)	(0.28)		(0.21)	(0.20)	—
EPS (diluted) ($)	(0.28)		(0.21)	(0.20)	—
Weighted avg. shares (basic)	12,755		14,523	14,890
Weighted avg. shares (diluted)	12,755		14,523	14,890

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 50 more quarters, back to Mar 2013, with Tormere Pro.

Corporate Events (8-K)

25 filings in 12 months · 3 with priority itemsFull history →

Filed	Items	Filing
Oct 2, 2026 accepted 4:01 PM ET	3.01Delisting notice	Document SEC ↗
Oct 1, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 11, 2026 accepted 4:29 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Sep 9, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 17, 2026 accepted 8:35 AM ET	1.01Material agreement3.02Unregistered equity sale8.01Other events	Document SEC ↗
Aug 13, 2026 accepted 4:02 PM ET	2.02Earnings release	Document SEC ↗
Jul 24, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 17, 2026 accepted 4:07 PM ET	3.01Delisting notice	Document SEC ↗
Jul 13, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure	Document SEC ↗
Jun 22, 2026 accepted 9:00 AM ET	7.01Reg FD disclosure	Document SEC ↗